Ampio Pharmaceuticals (AMPE) Competitors $0.01 +0.01 (+∞) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends AMPE vs. CALA, VAXX, SCPS, ARDS, STAB, CMRA, EVLO, GNCA, EFTR, and ATNFWShould you be buying Ampio Pharmaceuticals stock or one of its competitors? The main competitors of Ampio Pharmaceuticals include Calithera Biosciences (CALA), Vaxxinity (VAXX), Scopus BioPharma (SCPS), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Comera Life Sciences (CMRA), Evelo Biosciences (EVLO), Genocea Biosciences (GNCA), eFFECTOR Therapeutics (EFTR), and 180 Life Sciences (ATNFW). These companies are all part of the "pharmaceutical products" industry. Ampio Pharmaceuticals vs. Calithera Biosciences Vaxxinity Scopus BioPharma Aridis Pharmaceuticals Statera Biopharma Comera Life Sciences Evelo Biosciences Genocea Biosciences eFFECTOR Therapeutics 180 Life Sciences Calithera Biosciences (NASDAQ:CALA) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership. Is CALA or AMPE more profitable? Company Net Margins Return on Equity Return on Assets Calithera BiosciencesN/A N/A N/A Ampio Pharmaceuticals N/A N/A N/A Does the MarketBeat Community believe in CALA or AMPE? Calithera Biosciences received 341 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 57.21% of users gave Calithera Biosciences an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCalithera BiosciencesOutperform Votes34157.21% Underperform Votes25542.79% Ampio PharmaceuticalsOutperform VotesNo VotesUnderperform Votes55100.00% Does the media refer more to CALA or AMPE? In the previous week, Calithera Biosciences and Calithera Biosciences both had 1 articles in the media. Calithera Biosciences' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Calithera Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ampio Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, CALA or AMPE? Ampio Pharmaceuticals has lower revenue, but higher earnings than Calithera Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalithera Biosciences$9.75M0.00-$39.65MN/AN/AAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00 Do institutionals and insiders hold more shares of CALA or AMPE? 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, CALA or AMPE? Calithera Biosciences has a beta of -1.09, suggesting that its share price is 209% less volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.73, suggesting that its share price is 273% more volatile than the S&P 500. SummaryCalithera Biosciences beats Ampio Pharmaceuticals on 4 of the 7 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMPE vs. The Competition Export to ExcelMetricAmpio PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$11,000.00$6.50B$5.09B$20.10BDividend YieldN/A8.11%5.04%3.49%P/E Ratio0.005.4594.6037.65Price / SalesN/A373.721,217.5218.50Price / CashN/A52.5939.4921.28Price / Book0.0010.266.954.64Net Income-$8.63M$153.22M$118.83M$985.06M Ampio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMPEAmpio PharmaceuticalsN/A$0.01+∞N/A-99.6%$11,000.00N/A0.0020Gap DownCALACalithera BiosciencesN/A$0.01flatN/A-76.0%$35,000.00$9.75M0.0060VAXXVaxxinityN/A$0.00flatN/A-100.0%$25,000.00$70,000.000.0090SCPSScopus BioPharmaN/A$0.00flatN/A-99.3%$13,000.00N/A0.009ARDSAridis PharmaceuticalsN/AN/AN/AN/A$10,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/A+0.0%$10,000.00$1.49M0.0020CMRAComera Life SciencesN/A$0.00flatN/A-99.5%$9,000.00$630,000.000.002EVLOEvelo BiosciencesN/A$0.00-66.7%N/A-99.7%$9,000.00N/A0.00120News CoverageGap DownGNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastEFTReFFECTOR Therapeutics1.2787 of 5 stars$0.00flat$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010Negative NewsATNFW180 Life SciencesN/A$0.01-11.1%N/A-25.0%$0.00N/A0.007Gap Down Related Companies and Tools Related Companies Calithera Biosciences Competitors Vaxxinity Competitors Scopus BioPharma Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Comera Life Sciences Competitors Evelo Biosciences Competitors Genocea Biosciences Competitors eFFECTOR Therapeutics Competitors 180 Life Sciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:AMPE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
